Leerink Partners raises Lexeo Therapeutics target price to $23 from $15
LXEO•Leerink Partners raised its target price for Lexeo Therapeutics to $23 from $15.
Related News

People react to US AI chip curbs that threaten data centre boom
NVDA•

Quirón study finds AI responses on kidney cancer guidelines win 92%-96% expert agreement
FSNUY•

Steel Dynamics Inc: Jefferies cuts target price to $280 from $310
STLD•

Grail CFO Aaron Freidin reports sale of 3,000 common shares for $322,866.97
GRAL•

Ivanhoe Mines: Jefferies cuts target price to C$8.50 from C$11
IVPAF•